The store will not work correctly in the case when cookies are disabled.
JavaScript seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Javascript in your browser.
Home
Catalog Products
Nucleoside Triphosphates & Nucleotides
Sugar Modified NTPs
2'-O-Methyluridine-5'-Triphosphate
2'-O-Methyluridine-5'-Triphosphate
2'-O-Methyluridine-5'-Triphosphate - (N-1018)
2'-O-Methyl-UTP, 2'OMe-UTP
Product Details
Catalog No
N-1018
Purity
≥90% by AX-HPLC
Extinction Coefficient
10,100 Lmol-1 cm-1 at 262 nm
Molecular Formula
C10 H17 N2 O15 P3 (free acid)
Molecular Weight
498.10 g/mole (free acid)
Salt Form
Li+
Concentration
100 mM
Buffer
H2 O
Recommended Storage
-20°C or below
Other Name(s)
2'-O-Methyl-UTP, 2'OMe-UTP
Application
Aptamers, Epigenetics/DNA Damage
Backbone
5'-Triphosphate
Base Analog(s)
Uridine
Sugar Type(s)
2'-O-Methyl
Nucleotide Category
Sugar Modified
Intellectual Property
Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission of Seller. No license under any patent or other intellectual property right of Seller or its licensors is granted or implied by the purchase unless otherwise provided in writing.
TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser's sole responsibility.
References
Karikó, Katalin; Muramatsu, Hiromi; Welsh, Frank A.; Ludwig, János; Kato, Hiroki; Akira, Shizuo; Weissman, Drew . Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.
Xiao, Zeyu; Levy-Nissenbaum, Etgar; Alexis, Frank; Lupták, Andrej; Teply, Benjamin A.; Chan, Juliana M.; Shi, Jinjun; Digga, Elise; Cheng, Judy; Langer, Robert; Farokhzad, Omid C. . Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection.
Kanwar, Jagat R.; Roy, Kislay; Kanwar, Rupinder K. . Chimeric aptamers in cancer cell-targeted drug delivery.
Lauridsen, Lasse H.; Rothnagel, Joseph A.; Veedu, Rakesh N. . Enzymatic recognition of 2'-modified ribonucleoside 5'-triphosphates: towards the evolution of versatile aptamers.
Green, Nathaniel M.; Moody, Krishna-Sulayman; Debatis, Michelle; Marshak-Rothstein, Ann . Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands.
Lai, Zijuan; Tsugawa, Hiroshi; Wohlgemuth, Gert; Mehta, Sajjan; Mueller, Matthew; Zheng, Yuxuan; Ogiwara, Atsushi; Meissen, John; Showalter, Megan; Takeuchi, Kohei; Kind, Tobias; Beal, Peter; Arita, Masanori; Fiehn, Oliver . Identifying metabolites by integrating metabolome databases with mass spectrometry cheminformatics.
Request a Quote
""
